Prestige Brands Holdings, Inc. First Quarter Earnings Sneak Peek

Prestige Brands Holdings, Inc. (NASDAQ:PBH) will unveil its latest earnings on Thursday, August 4, 2011. Prestige Brands Holdings, Inc. sells well-recognized, brand name over-the-counter healthcare, household cleaning and personal care products in a global marketplace.

Prestige Brands Holdings, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of 23 cents per share, a rise of 15% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged and it has not changed during the last month. For the year, analysts are projecting net income of 97 cents per share, a rise of 22.8% from last year.

Past Earnings Performance: The company met estimates last quarter after beating the forecasts in the prior two. In the fourth quarter of the last fiscal year, the company reported profit of 18 cents per share versus a mean estimate of net income of 18 cents per share. In the third quarter of the last fiscal year, the company beat estimates by 2 cents.

Get more Earnings Cheat Sheets with our in depth coverage of earnings season >>

Wall St. Revenue Expectations: On average, analysts predict $95.4 million in revenue this quarter, a rise of 29.9% from the year ago quarter. Analysts are forecasting total revenue of $407.9 million for the year, a rise of 21.2% from last year’s revenue of $336.5 million.

Analyst Ratings: Analysts are bullish on Prestige Brands Holdings as two analysts rate it as a buy, one rates it as a sell and three rate it as a hold.

Key Stats:

The company has now been profitable for the last eight quarters, and for the last four, profit has risen year over year by an average of 10.5%. The quarter with the biggest boost was the most recent quarter, which saw a 95.1% surge.

The company’s revenue has now risen for two straight quarters. In fourth quarter of the last fiscal year, revenue increased 35% to $96.4 million from the year earlier quarter. In the third quarter of the last fiscal year, the figure rose 20.1%.

Competitors to Watch: The Procter & Gamble Co. (NYSE:PG), Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK), Perrigo Company (NASDAQ:PRGO), Watson Pharmaceuticals, Inc. (NYSE:WPI), Hi-Tech Pharmacal Co. (NASDAQ:HITK), Allergan, Inc. (NYSE:AGN), GlaxoSmithKline plc (NYSE:GSK), and Akorn, Inc. (NASDAQ:AKRX).

Stock Price Performance: During May 4, 2011 to July 29, 2011, the stock price had risen $1.06 (9.5%) from $11.16 to $12.22. The stock price saw one of its best stretches over the last year between September 21, 2010 and September 29, 2010 when shares rose for seven-straight days, rising 12.7% (+$1.12) over that span. It saw one of its worst periods between March 9, 2011 and March 17, 2011 when shares fell for seven-straight days, falling 11.2% (-$1.41) over that span. Shares are up 27 cents (+2.3%) year to date.

(Source: Xignite Financials)

Get more Earnings Cheat Sheets with our in depth coverage of earnings season >>